Insider Holders & Insider Ownership - Neurogene Inc. (NGNE)

List of insiders holdings for Neurogene Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
# Insider Holder Name Report
Date Time		 Shares Owned
Directly
Indirectly		 Total
Shares Owned		 Filing
1 BAKER BROS. ADVISORS LP
667 L.P.
BAKER FELIX
BAKER JULIAN
Baker Bros. Advisors (GP) LLC
Baker Brothers Life Sciences LP
Former 10% Owner
Director		 2023-12-20 18:43:06 226
7,831,540		 7,831,766 Form 4
2 Samsara BioCapital GP LLC
Samsara BioCapital L.P.
AKKARAJU SRINIVAS
10% Owner		 2024-11-27 16:39:29 0
1,717,127		 1,717,127 Form 4
3 Redmile Group LLC
Green Jeremy
10% Owner		 2025-02-14 20:01:27 1,479,766
0		 1,479,766 Form 13G
4 McMinn Rachel
Chief Executive Officer		 2025-03-28 21:27:40 1,417,759
0		 1,417,759 Form 4
5 Ventures West 8 Limited Partnership
10% Owner		 2016-02-16 15:21:10 1,020,430
0		 1,020,430 Form 13G
6 PFIZER INC
10% Owner		 2015-08-18 17:05:42 481,529
0		 481,529 Form 13G
7 Main David
President and CEO		 2018-08-09 19:07:07 415,000
0		 415,000 Form 4
8 DRACHMAN JONATHAN G
President and CEO		 2022-08-04 16:38:51 350,000
0		 350,000 Form 4
9 Cvijic Christine Mikail
President and CFO		 2025-03-28 21:29:40 214,643
0		 214,643 Form 4
10 Alam Kamran
CFO, Vice President Finance		 2018-08-09 19:03:08 195,000
0		 195,000 Form 4
11 Walkey Carl
Senior Vice President		 2022-08-04 16:43:37 150,000
0		 150,000 Form 4
12 MacKenzie Lloyd
Chief Operating Officer		 2018-08-09 19:04:32 145,000
0		 145,000 Form 4
13 Cochener Donna
General Counsel, SVP Legal		 2022-08-04 16:37:38 100,000
0		 100,000 Form 4
14 Vance Holly
General Counsel		 2021-08-05 16:25:06 100,000
0		 100,000 Form 4
15 Jenkins Abigail
Chief Commercial Officer		 2018-03-13 16:53:32 75,000
0		 75,000 Form 4
16 Troupin Barbara
Chief Medical Officer		 2018-03-13 17:04:31 75,000
0		 75,000 Form 4
17 McCloskey Shelley
VP, HR and Administration		 2018-08-09 19:05:37 75,000
0		 75,000 Form 4
18 Cobb Stuart
Chief Scientific Officer		 2025-03-28 21:30:38 70,491
0		 70,491 Form 4
19 Ho Robert
Chief Financial Officer		 2022-02-02 16:36:59 70,000
0		 70,000 Form 4
20 Jordan Julie
Chief Medical Officer		 2025-03-28 21:28:27 58,700
0		 58,700 Form 4
21 Patel Priti
Former Chief Medical Officer		 2023-04-04 20:51:03 37,313
0		 37,313 Form 4
22 SHREWSBURY STEPHEN B
CMO; Senior VP Clinical Dev.		 2016-03-14 17:42:11 35,000
0		 35,000 Form 4
23 Nolan Sean P.
Director		 2020-05-07 16:25:33 25,000
0		 25,000 Form 4
24 Mitchell David Chilton
VP Global Regulatory & Quality		 2017-03-10 21:20:07 25,000
0		 25,000 Form 4
25 SIMPSON TODD E
Director		 2023-06-09 16:28:18 25,000
0		 25,000 Form 4
26 Lavelle Erin
Director		 2023-06-09 16:25:32 25,000
0		 25,000 Form 4
27 Babler Martin
Director		 2023-06-09 16:24:41 25,000
0		 25,000 Form 4
28 Williams Lewis T
Director		 2021-05-13 17:39:26 25,000
0		 25,000 Form 4
29 Lavelle Erin M.
Director		 2021-05-13 17:37:13 25,000
0		 25,000 Form 4
30 Smith Sean Michael
Interim CFO, Prin Acct Off		 2023-08-14 16:06:55 21,637
0		 21,637 Form 4
31 Bridger Gary
Director		 2018-05-09 18:15:59 15,000
0		 15,000 Form 4
32 Pelzer Robert
Director		 2018-05-09 18:17:37 15,000
0		 15,000 Form 4
33 Freedland Cory S.
Director		 2024-06-17 14:35:37 7,700
0		 7,700 Form 4
34 Noonberg Sarah B.
Director		 2024-06-17 14:36:03 7,700
0		 7,700 Form 4
35 BAFFI ROBERT
Director		 2024-06-17 14:36:28 7,700
0		 7,700 Form 4
36 PALEKAR ROHAN
Director		 2024-06-17 14:37:01 7,700
0		 7,700 Form 4
37 Woods Robert Keith
Director		 2024-06-17 14:37:33 7,700
0		 7,700 Form 4
38 Neu Kelvin
Director		 2017-03-27 18:07:32 36
0		 36 Form 3
39 LEVITT DANIEL J
Director		 2018-05-16 19:45:26 0
0		 0 Form 4
40 Levy Richard S
Director		 2017-03-27 17:04:42 0
0		 0 Form 3
41 Boyd Meta Cantey
Director		 2019-08-23 15:58:29 0
0		 0 Form 3
42 JOHNSON & JOHNSON
Johnson & Johnson Innovation - JJDC Inc.
10% Owner		 2016-02-12 15:19:26 0
0		 0 Form 13G
43 Jones Elaine V
Director		 2014-03-06 17:25:34 0
0		 0 Form 3